PRODUCT DETAILS

About Arbitel-Trio 50 Tablet ER

CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN belongs to the group of anti-hypertensive medicines used to treat high blood pressure (hypertension). CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN helps lower blood pressure, thereby reducing the chances of heart problems such as heart attack and stroke. High blood pressure is a condition in which the blood exerts increased pressure on the walls of blood vessels. Symptoms include headache, dizziness, nosebleeds, changes in vision, chest pain, weakness, and dyspnea (shortness of breath). However, most of the time, the signs and symptoms of hypertension are none.
 
CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN is a combination of three drugs, namely: Cilnidipine, Telmisartan, and Metoprolol succinate. Cilnidipine acts on the calcium channels of the blood vessels and suppresses the contraction of blood vessels, thereby helping the blood flow smoothly. Telmisartan works by blocking the angiotensin II receptor, thereby relaxing the blood vessels and lowering the blood pressure. Metoprolol succinate slows down the rate and makes it easier for the heart to pump blood throughout the body. Together, CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN helps treat hypertension.
 
Take CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN as prescribed. You are advised to take CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience certain common side-effects such as headache, nausea, dizziness, weakness, decreased blood pressure, and slow heart rate. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
 
Try not to stop taking CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN on your own as it may cause a sudden increase in blood pressure. Consult your doctor before taking CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN if you are pregnant or breastfeeding. CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN is not recommended for children as efficacy and safety have not been established. CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN may cause dizziness, so drive with caution. Avoid consuming alcohol as it might cause increased dizziness. Inform your doctor about all the medicines you are taking and about your health condition to rule out any unpleasant side effects/interactions.

Uses of Arbitel-Trio 50 Tablet ER

Hypertension (high blood pressure)

Medicinal Benefits of Arbitel-Trio 50 Tablet ER

CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN is a combination of three drugs, namely: Cilnidipine, Telmisartan, and Metoprolol succinate. CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN is used to treat hypertension. Cilnidipine is a calcium channel blocker that acts on the calcium channels of the blood vessels and suppresses the contraction of blood vessels, thereby helping the blood flow smoothly. Telmisartan is an angiotensin receptor blocker that works by blocking the angiotensin II receptor, thereby relaxing the blood vessels and lowering the blood pressure. Metoprolol succinate is a beta-blocker that slows down the rate and makes it easier for the heart to pump blood throughout the body. Together, CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN helps treat hypertension. CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN helps lower blood pressure, thereby reducing the chances of heart problems such as heart attack and stroke.

Directions for Use

Take CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN with or without food. Swallow CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN as a whole with a glass of water; do not crush, break or chew the tablet. Based on your medical condition, your doctor will advise for how long you need to take CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN.

Side Effects of Arbitel-Trio 50 Tablet ER

• Headache
• Nausea
• Weakness
• Slow heart rate (bradycardia)
• Dizziness

Similar Drugs

For informational purposes only. Consult a doctor before taking any medicines.

In-Depth Precautions and Warning

Drug Warnings

Do not take CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN if you are allergic to any of its contents. Inform your doctor before taking CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN if you have diabetes, circulation problems, asthma, thyroid disorder, adrenal gland tumor, heart, kidney, or liver problems; if you are on a low-salt diet or if you are taking potassium supplements. Consult your doctor before taking CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN if you are pregnant or breastfeeding. CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN is not recommended for children as efficacy and safety have not been established. CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN may cause dizziness, so drive with caution. Avoid consuming alcohol as it might cause increased dizziness. Rise slowly from lying/sitting position as CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN may cause dizziness (orthostatic hypotension).

Drug Interactions

Drug-Drug Interaction:

CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN may have interaction with medicines such as painkillers (aspirin), anti-convulsant (pregabalin, phenytoin), anti-depressant (duloxetine), anti-diabetic (insulin glargine), diuretic (furosemide), hormone (levothyroxine), antibiotics (erythromycin, rifampicin), anti-arrhythmic agent (quinidine), cytokines (aldesleukin).

Drug-Disease Interaction:

CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN may have interactions with conditions such as diabetes, renal dysfunction (kidney disease), pulmonary disease, alcoholism, congestive heart failure (heart disease), hypotension (low blood pressure), and liver disease.

Safety Advice

ALCOHOL

Avoid consuming alcohol as it might cause increased dizziness.

PREGNANCY

Please consult your doctor before taking CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN if you are pregnant; your doctor will prescribe only if the benefits outweigh the risks.

BREAST FEEDING

Please consult your doctor before taking CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN; your doctor will decide whether CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN can be given to breastfeeding mothers or not.

DRIVING

CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN may cause dizziness, but do not drive or operate heavy machinery if you feel dizzy.

LIVER

• Dose adjustment may be needed. CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN should be used with caution in patients with liver impairment/liver disease. Please consult your doctor if you have liver problems or any concerns regarding this.

 

KIDNEY

Dose adjustment may be needed. CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN should be used with caution in patients with kidney impairment/kidney disease. Please consult your doctor if you have kidney problems or any concerns regarding this.